What the media is reporting about MassBio
News from the biotechnology industry
Showing news: 381–390 of 393
September 12, 2008 —
On September 9th, MBC hosted dozens of cancer research companies at a forum to learn about new funding opportunities being offered by the National Cancer Institute. Michael Weingarten and David Beylin from NCI's SBIR program outlined 18 new…
August 27, 2008 —
August 27, 2008—It has been one year since Bob Coughlin took the reins at MBC. In this letter, he shares information on what the council has been doing for members this past year—and where the organization is going next.
August 20, 2008 —
MBC congratulates Dyax for Phase 3 Trial success!
August 4, 2008 —
Measure Will Allow Companies to Redeem Earned but Unusable Tax Credits for CashPresident Bush has signed multi-billion dollar legislation addressing the nation's mortgage and housing crises that also contains an economic stimulus jolt for the…
July 30, 2008 —
After five years of frustration in Congress, biotechnology companies with significant venture capital backing are on the verge of once again qualifying for SBIR (Small Business Innovation Research) grants, thanks in large measure to the persistent advocacy…
June 25, 2008 —
On June 16, at Boston's Joslin Diabetes Center, Massachusetts Governor Deval Patrick signed into law the state's landmark Life Sciences Initiative (LSI), then immediately flew to San Diego with legislative leadership to tout the plan in front of…
April 30, 2008 —
MBC Played Advocacy Role to Help Biotech Companies
Become Eligible for Federal Grants Once Again
Download the complete text of the letter MBC sent to MA Congressional delegation on SBIR issue by clicking here.
On Wednesday, April…
April 29, 2008 —
Click here to download the PDF version.
April 4, 2008 —
Listen to EMD Serono's Message of Hope
EMD Serono, Inc. is a leader in the US biopharmaceutical arena, integrating cutting-edge science with unparalleled patient support systems to improve people's lives. With fully…
April 4, 2008 —
Listen to Alnylam's Message of Hope
Alnylam Pharmaceuticals was founded in 2002 and now has approximately 110 employees. Based in Cambridge, Mass, the company is a leader in the development of RNAi therapeutics. …